Planning Ahead: Using Phase 2 to Anticipate Phase 3 Clinical Supply Challenges & Solutions
Summary: While clinical studies are in Phase 2, it is important for sponsors to be prepared for any Phase 3 challenges that might arise. Understanding what resources are available is key to being ready for Phase 3 before it even begins.
What are some possible challenges sponsors might encounter during Phase 3? In what ways can sponsors enhance their study protocols and improve supply chain efficiencies? How can sponsors mitigate risk to help ensure smooth study execution and accurate data collection?